Safety and efficacy of long-term disulfiram aftercare

Clinical Neuropharmacology

Volumn 34, Issue 5, 2011, Pages 195-198

  Mutschler, Jochen ^a,b   Dirican, Gülseren ^b   Gutzeit, Andreas ^c   Grosshans, Martin ^b  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIRAM; LIVER ENZYME;

ADULT; AFTERCARE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLISM; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; DEPRESSION; DETOXIFICATION; DIZZINESS; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPATITIS; HUMAN; LACTIC ACIDOSIS; LONG TERM CARE; MALE; MEAN CORPUSCULAR VOLUME; MYALGIA; POLYNEUROPATHY; PRIORITY JOURNAL; RELAPSE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN DISEASE; TREATMENT OUTCOME;

ADULT; AFTERCARE; AGED; ALCOHOL DETERRENTS; ALCOHOLISM; DISULFIRAM; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 80053053905     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3182285e2d     Document Type: Article

References (14)

1. Heilig M, Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 2006;111:855-876. (Pubitemid 44118437)
2. Spanagel R, Kiefer F. Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol Sci 2008;29:109-115.
3. Krampe H, Ehrenreich H. Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des 2010;16:2076-2090.
4. Ojehagen A, Skjaerris A, Berglund M. Long-term use of aversive drugs in outpatient alcoholism treatment. Acta Psychiatr Scand 1991;84:185-190.
5. Mueser KT, Noordsy DL, Fox L, et al. Disulfiram treatment for alcoholism in severe mental illness. Am J Addict 2003;12:242-252. (Pubitemid 36950973)
6. Krampe H, Stawicki S, Wagner T et al. Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res 2006;30:86-95. (Pubitemid 43341400)
7. Mutschler J, Grosshans M, Koopmann A, et al. Urinary ethylglucuronide assessment in patients treated with disulfiram: a tool to improve verification of abstention and safety. Clin Neuropharmacol 2010;33:285-287.
8. Diehl A, Ulmer L, Mutschler J, et al. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients. Alcohol Alcohol 2010;45:271-277.
9. Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006;295:2003-2017. (Pubitemid 44794003)
10. Kiefer F, Jahn H, Tarnaske T, et al. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2003;60:92-99. (Pubitemid 36070869)
11. Mutschler J, Diehl A, Vollmert C, et al. Recent results in relapse prevention of alcoholism with disulfiram [in German]. Neuropsychiatr 2008;22:243-251.
12. Fuller RK, Branchey L, Brightwell DR, et al. Disulfiram treatment of alcoholism. AVeterans Administration cooperative study. JAMA 1986;256:1449-1455. (Pubitemid 16014332)
13. Ehrenreich H, Krampe H. Does disulfiram have a role in alcoholism treatment today? Not to forget about disulfiram's psychological effects. Addiction 2004;99:26-27; author reply 27-28. (Pubitemid 38142219)
14. Mutschler J, Dirican G, Funke S, et al. Experienced acetaldehyde reaction does not improve treatment response in outpatients treated with supervised disulfiram. Clin Neuropharmacol 2011;34:161-165.